Development and implementation of a national antimicrobial stewardship surveillance system, with open access data sharing

Diane Ashiru Oredope; E. L. Budd; A. Doble; E. Cramp; A. Hendrick; Susan Hopkins

doi:10.1016/j.jhin.2020.10.015

Development and implementation of a national antimicrobial stewardship surveillance system, with open access data sharing

Diane Ashiru Oredope^*, E. L. Budd, A. Doble, E. Cramp, A. Hendrick, Susan Hopkins

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

Abstract

Background: Public Health England (PHE) developed an antimicrobial stewardship (AMS) surveillance system and conducted a national pilot to test the feasibility of centrally collecting data from AMS audits performed by NHS hospital trusts. The system was simplified, focusing on requirements of the NHS AMR CQUIN (Commissioning for Quality and Innovation; a financial incentive quality improvement scheme).

Aim: To present results and user feedback from the national pilot, and results from using the AMS surveillance system as part of the AMR CQUIN.

Methods: An AMS surveillance system was developed and a national pilot conducted in which 33 NHS trusts submitted data and feedback on system utilization. The system was refined based on feedback and deployed nationally to collect AMS data for the 2016-17 AMR CQUIN.

Findings: Most trusts participating in the pilot collected data on documentation of indication (90%). Fewer collected data on documenting review decisions at 48-72 h (36%). On average 83% of patients had an indication documented, whereas 71% had formal documentation of 48-72 h review. AMR CQUIN data were submitted by 88% of trusts for at least one quarter of 2016-17. Approximately 92% of prescriptions had an indication documented and 87.5% of prescriptions had evidence of review within 72 h; these increased by 7 and 10 percentage points respectively between the first and final quarters.

Conclusion: The AMS surveillance system allowed AMS audit data from NHS trusts in England to be collected centrally. PHE publishes these data openly online, on PHE Fingertips portal, a national public health data portal. The reported data highlight improvement in the percentage of antibiotic prescriptions with evidence of a documented review within 72 h. Crown Copyright (C) 2020 Published by Elsevier Ltd on behalf of The Healthcare Infection Society. All rights reserved.

Original language	English
Pages (from-to)	16-22
Number of pages	7
Journal	Journal of Hospital Infection
Volume	107
DOIs	https://doi.org/10.1016/j.jhin.2020.10.015
Publication status	Published - Jan 2021

Bibliographical note

Funding Information:
O. Oloyede is acknowledged for statistical support at the later stages of the article preparation. We thank all the hospital sites and colleagues who contributed to development of the AMS surveillance system by participating in the pilot and who used it to identify requirements of the AMR CQUIN scheme. The study did not receive additional or external funding.

Keywords

Antibiotic
Antimicrobial resistance
Antimicrobial stewardship
Data
Public health
Surveillance
START SMART
RESISTANCE
PROGRAM

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jhin.2020.10.015

Cite this

@article{307b990e95ca4e6aa0deb62a94f5c990,

title = "Development and implementation of a national antimicrobial stewardship surveillance system, with open access data sharing",

abstract = "Background: Public Health England (PHE) developed an antimicrobial stewardship (AMS) surveillance system and conducted a national pilot to test the feasibility of centrally collecting data from AMS audits performed by NHS hospital trusts. The system was simplified, focusing on requirements of the NHS AMR CQUIN (Commissioning for Quality and Innovation; a financial incentive quality improvement scheme).Aim: To present results and user feedback from the national pilot, and results from using the AMS surveillance system as part of the AMR CQUIN.Methods: An AMS surveillance system was developed and a national pilot conducted in which 33 NHS trusts submitted data and feedback on system utilization. The system was refined based on feedback and deployed nationally to collect AMS data for the 2016-17 AMR CQUIN.Findings: Most trusts participating in the pilot collected data on documentation of indication (90%). Fewer collected data on documenting review decisions at 48-72 h (36%). On average 83% of patients had an indication documented, whereas 71% had formal documentation of 48-72 h review. AMR CQUIN data were submitted by 88% of trusts for at least one quarter of 2016-17. Approximately 92% of prescriptions had an indication documented and 87.5% of prescriptions had evidence of review within 72 h; these increased by 7 and 10 percentage points respectively between the first and final quarters.Conclusion: The AMS surveillance system allowed AMS audit data from NHS trusts in England to be collected centrally. PHE publishes these data openly online, on PHE Fingertips portal, a national public health data portal. The reported data highlight improvement in the percentage of antibiotic prescriptions with evidence of a documented review within 72 h. Crown Copyright (C) 2020 Published by Elsevier Ltd on behalf of The Healthcare Infection Society. All rights reserved.",

keywords = "Antibiotic, Antimicrobial resistance, Antimicrobial stewardship, Data, Public health, Surveillance, START SMART, RESISTANCE, PROGRAM",

author = "{Ashiru Oredope}, Diane and Budd, {E. L.} and A. Doble and E. Cramp and A. Hendrick and Susan Hopkins",

note = "Funding Information: O. Oloyede is acknowledged for statistical support at the later stages of the article preparation. We thank all the hospital sites and colleagues who contributed to development of the AMS surveillance system by participating in the pilot and who used it to identify requirements of the AMR CQUIN scheme. The study did not receive additional or external funding.",

year = "2021",

month = jan,

doi = "10.1016/j.jhin.2020.10.015",

language = "English",

volume = "107",

pages = "16--22",

journal = "Journal of Hospital Infection",

issn = "0195-6701",

publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Development and implementation of a national antimicrobial stewardship surveillance system, with open access data sharing

AU - Ashiru Oredope, Diane

AU - Budd, E. L.

AU - Doble, A.

AU - Cramp, E.

AU - Hendrick, A.

AU - Hopkins, Susan

N1 - Funding Information: O. Oloyede is acknowledged for statistical support at the later stages of the article preparation. We thank all the hospital sites and colleagues who contributed to development of the AMS surveillance system by participating in the pilot and who used it to identify requirements of the AMR CQUIN scheme. The study did not receive additional or external funding.

PY - 2021/1

Y1 - 2021/1

N2 - Background: Public Health England (PHE) developed an antimicrobial stewardship (AMS) surveillance system and conducted a national pilot to test the feasibility of centrally collecting data from AMS audits performed by NHS hospital trusts. The system was simplified, focusing on requirements of the NHS AMR CQUIN (Commissioning for Quality and Innovation; a financial incentive quality improvement scheme).Aim: To present results and user feedback from the national pilot, and results from using the AMS surveillance system as part of the AMR CQUIN.Methods: An AMS surveillance system was developed and a national pilot conducted in which 33 NHS trusts submitted data and feedback on system utilization. The system was refined based on feedback and deployed nationally to collect AMS data for the 2016-17 AMR CQUIN.Findings: Most trusts participating in the pilot collected data on documentation of indication (90%). Fewer collected data on documenting review decisions at 48-72 h (36%). On average 83% of patients had an indication documented, whereas 71% had formal documentation of 48-72 h review. AMR CQUIN data were submitted by 88% of trusts for at least one quarter of 2016-17. Approximately 92% of prescriptions had an indication documented and 87.5% of prescriptions had evidence of review within 72 h; these increased by 7 and 10 percentage points respectively between the first and final quarters.Conclusion: The AMS surveillance system allowed AMS audit data from NHS trusts in England to be collected centrally. PHE publishes these data openly online, on PHE Fingertips portal, a national public health data portal. The reported data highlight improvement in the percentage of antibiotic prescriptions with evidence of a documented review within 72 h. Crown Copyright (C) 2020 Published by Elsevier Ltd on behalf of The Healthcare Infection Society. All rights reserved.

AB - Background: Public Health England (PHE) developed an antimicrobial stewardship (AMS) surveillance system and conducted a national pilot to test the feasibility of centrally collecting data from AMS audits performed by NHS hospital trusts. The system was simplified, focusing on requirements of the NHS AMR CQUIN (Commissioning for Quality and Innovation; a financial incentive quality improvement scheme).Aim: To present results and user feedback from the national pilot, and results from using the AMS surveillance system as part of the AMR CQUIN.Methods: An AMS surveillance system was developed and a national pilot conducted in which 33 NHS trusts submitted data and feedback on system utilization. The system was refined based on feedback and deployed nationally to collect AMS data for the 2016-17 AMR CQUIN.Findings: Most trusts participating in the pilot collected data on documentation of indication (90%). Fewer collected data on documenting review decisions at 48-72 h (36%). On average 83% of patients had an indication documented, whereas 71% had formal documentation of 48-72 h review. AMR CQUIN data were submitted by 88% of trusts for at least one quarter of 2016-17. Approximately 92% of prescriptions had an indication documented and 87.5% of prescriptions had evidence of review within 72 h; these increased by 7 and 10 percentage points respectively between the first and final quarters.Conclusion: The AMS surveillance system allowed AMS audit data from NHS trusts in England to be collected centrally. PHE publishes these data openly online, on PHE Fingertips portal, a national public health data portal. The reported data highlight improvement in the percentage of antibiotic prescriptions with evidence of a documented review within 72 h. Crown Copyright (C) 2020 Published by Elsevier Ltd on behalf of The Healthcare Infection Society. All rights reserved.

KW - Antibiotic

KW - Antimicrobial resistance

KW - Antimicrobial stewardship

KW - Data

KW - Public health

KW - Surveillance

KW - START SMART

KW - RESISTANCE

KW - PROGRAM

UR - http://www.scopus.com/inward/record.url?scp=85096188334&partnerID=8YFLogxK

U2 - 10.1016/j.jhin.2020.10.015

DO - 10.1016/j.jhin.2020.10.015

M3 - Article

C2 - 33122043

AN - SCOPUS:85096188334

SN - 0195-6701

VL - 107

SP - 16

EP - 22

JO - Journal of Hospital Infection

JF - Journal of Hospital Infection

ER -

Development and implementation of a national antimicrobial stewardship surveillance system, with open access data sharing

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this